RE:RE:RE:RE:RE:RE:RE:RE:AR is out on SEDARRoyal - do you really think this is the right time to add to the position in Ceapro?
The overall stock market looks so bad, Ceapro will not be able to escape.
With all the fantasy that Proph explains to us in detail every day, it will be important to turn it into an effective deal.
Performance over 5 years minus 60%, 3 years plus 22% and 1 year minus 25%. Inquiry about a narrow dividend in the amount of Gilles' annual salary was not answered, nor was the inquiry about a share buyback program.
Shareholder value looks different.
And please Proph don't tell us about your comparison of biotech indices - Ceapro. Only when we have sold a product, technology or license and generate $1 in revenue from it, do we belong in that category.